Tanweera Shaheena Khan

Reconsidering functional outcomes in watch-and-wait rectal cancer after total neoadjuvant treatment

Imam, Israa; Khan, Tanweera Shaheena; Nilsson, Per J.; Glimelius, Bengt

Part of Radiotherapy and Oncology, 2026

• DOI for Reconsidering functional outcomes in watch-and-wait rectal cancer after total neoadjuvant treatment

Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study

Imam, Israa; Nilsson, Per J.; Khan, Tanweera Shaheena; Angenete, Eva et al.

Part of BJS, 2026

• DOI for Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study
• Download full text (pdf) of Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study

Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US

Imam, Israa; Khan, Tanweera Shaheena; Nilsson, Per J; Glimelius, Bengt

Part of Radiotherapy and Oncology, 2026

• DOI for Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US
• Download full text (pdf) of Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Part of eClinicalMedicine, 2024

• DOI for Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Download full text (pdf) of Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Part of Neuroendocrinology, p. 330-343, 2021

• DOI for 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Download full text (pdf) of 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Reconsidering functional outcomes in watch-and-wait rectal cancer after total neoadjuvant treatment

Imam, Israa; Khan, Tanweera Shaheena; Nilsson, Per J.; Glimelius, Bengt

Part of Radiotherapy and Oncology, 2026

• DOI for Reconsidering functional outcomes in watch-and-wait rectal cancer after total neoadjuvant treatment

Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study

Imam, Israa; Nilsson, Per J.; Khan, Tanweera Shaheena; Angenete, Eva et al.

Part of BJS, 2026

• DOI for Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study
• Download full text (pdf) of Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study

Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US

Imam, Israa; Khan, Tanweera Shaheena; Nilsson, Per J; Glimelius, Bengt

Part of Radiotherapy and Oncology, 2026

• DOI for Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US
• Download full text (pdf) of Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Part of eClinicalMedicine, 2024

• DOI for Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Download full text (pdf) of Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Part of Neuroendocrinology, p. 330-343, 2021

• DOI for 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Download full text (pdf) of 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Sandström, Mattias; Freedman, Nanette; Fröss-Baron, Katarzyna; Khan, Tanweera et al.

Part of EJNMMI Physics, 2020

• DOI for Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
• Download full text (pdf) of Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Sandström, Mattias; Fröss-Baron, Katarzyna; Khan, Tanweera Shaheena; Granberg, Dan et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI for Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske, Ulrike; Sandström, Mattias; Fröss-Baron, Katarzyna; Lundin, Lars et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 970-988, 2018

• DOI for Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
• Download full text (pdf) of Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

One pot preparation of Ga-68-labelled macroaggregated albumin for PET-imaging of acute pulmonary embolism and myocardial perfusion quantification

Velikyan, Irina; Berhane, T.; Khan, Tanweera Shaheena; Borges, João Batista et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Vincristine, Cisplatin, Teniposide and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer

Khan, Tanweera Shaheena; Sundin, Anders; Juhlin, Claes; Wilander, Erik et al.

Part of Medical Oncology, p. 167-177, 2004

• DOI for Vincristine, Cisplatin, Teniposide and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer

11C-metomidate PET imaging of adrenocortical cancer

Khan, Tanweera Shaheena; Sundin, Anders; Juhlin, Claes; Långström, Bengt et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 403-410, 2003

Labelling of octreotide using Br-76-prosthetic groups

Yngve, Ulrika; Khan, Tanweera Shaheena; Bergström, Mats; Långstrom, Bengt

Part of Journal of labelled compounds & radiopharmaceuticals, p. 561-573, 2001

• DOI for Labelling of octreotide using Br-76-prosthetic groups

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use

Khan, Tanweera Shaheena; Imam, Hassan; Juhlin, Claes; Skogseid, Britt et al.

Part of Annals of Oncology, p. 1281-1287, 2000

PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

Bergström, Mats; Sörensen, Jens; Khan, Tanweera Shaheena; Juhlin, Claes et al.

Part of Clinical Positron Imaging, p. 339, 1999

• DOI for PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

New Diagnostic and Therapeutic Approaches in Adrenocortical Cancer

Khan, Tanweera Shaheena

2004

• Download full text (pdf) of New Diagnostic and Therapeutic Approaches in Adrenocortical Cancer

Expression of c-Kit, phospho-c-kit, PDGFRβ and absence of c-Kit mutation in exon 11 in adrenocortical cancer

Khan, Tanweera Shaheena; Gobl, Anders; Imam, Hassan; Juhlin, Claes et al.